Company News

Relievant Announces Completion of $58M Series E Financing to Support US Commercialization

Company to open corporate headquarters in Minneapolis, MN Minneapolis, MN – June 26, 2018 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the completion of a $58 million equity financing. The round was led by Endeavour Vision and [...]

2023-04-12T15:10:44+01:00June 26th, 2018|All News, Company News, Investment|

SOPHiA GENETICS acquires Interactive Biosoftware to drive growth and accelerate Data-Driven Medicine adoption around the world

Milan – Italy, June 16, 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic [...]

2023-04-03T14:43:15+01:00June 16th, 2018|All News, Company News|

Vertiflex Announces Appointments to Board of Directors, Ray Baker, MD, and Richard Mott

Vertiflex Announces Appointments to Board of Directors, Ray Baker, MD, and Richard Mott Company milestones demonstrate progress and commercial success of product portfolio CARLSBAD, Calif. – 8 June 2018 – Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced two new members [...]

2023-04-03T13:11:42+01:00June 8th, 2018|All News, Company News|

V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management [...]

2023-04-06T10:37:41+01:00April 26th, 2018|All News, Company News|

SOPHiA GENETICS announces CE-IVD marking of its genomic test for leukemia detection

The Myeloid Solution by SOPHiA GENETICS is the best-in-class molecular diagnostic application which empowers clinicians to more precisely diagnose hematological disorders Lausanne, SWITZERLAND – 06th February 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, unveiled today the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The [...]

2023-04-03T14:49:47+01:00February 6th, 2018|All News, Company News|

Gynesonics Announces Results from Pivotal IDE Trial for Incision Free Treatment for Uterine Fibroids

Results highlight robust Sonata System design and its potential to become a standard of care for fibroid treatment REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the results from their pivotal IDE trial for the [...]

2023-07-24T17:08:31+01:00January 9th, 2018|All News, Company News|

Endeavour Vision invests in surgical bone repairs specialist Medartis

Endeavour Vision invested in Medartis. Located in Basel, Switzerland, the company develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. Medartis was founded in 1997 by Dr. Thomas Straumann. The company launched its first products [...]

2023-07-24T16:54:56+01:00December 21st, 2017|All News, Blog, Company News, Investment|
Go to Top